Brad St Croix Selected Research

Brad St Croix Research Topics

Disease

28	Neoplasms (Cancer) 03/2024 - 01/2004
4	Neoplasm Metastasis (Metastasis) 10/2017 - 02/2006
2	Pathologic Neovascularization 02/2012 - 06/2007
2	Lewis Lung Carcinoma 02/2012 - 10/2007
1	Prostatic Neoplasms (Prostate Cancer) 10/2023
1	Starvation 11/2022
1	Neuroblastoma 01/2021
1	Triple Negative Breast Neoplasms 01/2018
1	Skin Abnormalities 03/2015
1	Fibrosis (Cirrhosis) 03/2015
1	Hemangioma (Angioma) 03/2015
1	Osteolysis 03/2015
1	Pseudoanodontia and Optic atrophy Alopecia Growth retardation 03/2015
1	Colonic Neoplasms (Colon Cancer) 06/2014
1	Mesothelioma 04/2013
1	Type I Syndactyly 04/2013
1	Anthrax 02/2012
1	Melanoma (Melanoma, Malignant) 02/2012
1	Hypoxia (Hypoxemia) 03/2008
1	Atherosclerosis 10/2007
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2004
6	AntibodiesIBA 12/2021 - 12/2004
4	Membrane Proteins (Integral Membrane Proteins)IBA 11/2022 - 01/2011
4	anthrax toxin receptorsIBA 03/2015 - 01/2004
3	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 10/2017
3	CollagenIBA 11/2022 - 02/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 03/2008
2	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2021
2	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 11/2023 - 10/2017
2	Monoclonal AntibodiesIBA 01/2022 - 04/2013
2	AntigensIBA 01/2021 - 01/2018
2	EpitopesIBA 01/2021 - 04/2013
2	anthrax toxin (anthrax lethal factor)IBA 01/2018 - 02/2004
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2015 - 11/2014
2	Cell Surface ReceptorsIBA 11/2014 - 06/2012
2	Angiogenesis InhibitorsIBA 06/2014 - 02/2012
1	LuciferasesIBA 03/2024
1	LigandsIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Neutralizing AntibodiesIBA 11/2022
1	Glutamine (L-Glutamine)FDA Link 11/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	DisulfidesIBA 12/2021
1	CathepsinsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	GlypicansIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	ProdrugsIBA 01/2018
1	CytokinesIBA 01/2018
1	Collagen ReceptorsIBA 01/2018
1	10-N-nonylacridinium orange (NAO)IBA 03/2015
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2014
1	Dinoprostone (PGE2)FDA Link 06/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2014
1	Peptides (Polypeptides)IBA 04/2013
1	Complement System Proteins (Complement)IBA 04/2013
1	Immunotoxins (Immunotoxin)IBA 04/2013
1	Single-Domain AntibodiesIBA 04/2013
1	MesothelinIBA 04/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012
1	Antineoplastic Agents (Antineoplastics)IBA 02/2012
1	ErbB Receptors (EGF Receptor)IBA 02/2012
1	Phosphotransferases (Kinase)IBA 02/2012
1	vandetanib (ZD6474)IBA 02/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2011
1	IntegrinsIBA 01/2011
1	Blood Proteins (Serum Proteins)IBA 03/2008
1	Apolipoproteins E (ApoE)IBA 10/2007
1	Antimitotic AgentsIBA 10/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2007
1	Messenger RNA (mRNA)IBA 12/2004
1	CortactinIBA 12/2004
1	Bevacizumab (Avastin)FDA Link 01/2004

Therapy/Procedure

18	Therapeutics 11/2023 - 01/2004
1	Castration 10/2023
1	Immunotherapy 10/2023
1	Chemoprevention 08/2014
1	Transplantation 02/2006